Nomoto Y, Takai H, Ohno T, Kubo K
Pharmaceutical Research Laboratories, Fuji Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
Chem Pharm Bull (Tokyo). 1991 Feb;39(2):352-7. doi: 10.1248/cpb.39.352.
Several benzothiazolyl, imidazobenzothiazolyl, benzothienyl, benzothienopyrimidinyl and quinazolinyl 4,5-dihydro-3(2H)-pyridazinones were synthesized and examined for cardiotonic activity in anesthetized dogs after i.v. administration. Among them, 4-methylamino-7-(2,3,4,5-tetrahydro-5-methyl-3-oxo-6- pyridazinyl)quinazoline (36) showed potent and long-lasting inotropic activity (relative potency = 2.11, milrinone = 1). The activity of 36 was more potent than indolidan (2) (relative potency = 1.53) which is one of the most potent inotropic agents to date.